Liquidia Corporation (NASDAQ:LQDA) Stock Has Average Target Price of $75.23 According to Brokerages

Shares of Liquidia Corporation (NASDAQ:LQDA – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twelve ratings firms that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $75.23.

LQDA has been the subject of several analyst reports. Jefferies Financial Group boosted their price objective on Liquidia from $55.00 to $62.00 and gave the stock a “buy” rating in a research report on Tuesday, November 10th. Bank of America set a $54.00 price target on Liquidia and gave the stock a “neutral” rating in a research report on Wednesday, November 11th. Lifesci Capital raised Liquidia from a “hold” rating to an “outperform” rating and set a $59.00 price target for the company in a research note on Wednesday, October 14th. Raymond James Financial raised Liquidia from an “outperform” rating to a “strong-buy” rating and raised their price target for the company from $53.00 to $77.00 in a report on Wednesday, November 11th. Finally, Zacks Research raised shares of Liquidia from a “strong sell” rating to a “hold” rating in a report on Thursday, November 12th.

Check Out Our Latest Analysis on Liquidia

Liquidia Price Performance

Shares of LQDA opened at $54.43 on Tuesday. Liquidia has a 12 month low of $22.31 and a 12 month high of $93.61. The company has a market cap of $4.90 billion, a P/E ratio of -44.25 and a beta of 0.40. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.02 and a quick ratio of 0.96. The stock has a fifty day moving average price of $47.77 and a 200 day moving average price of $55.06.

Liquidia (NASDAQ:LQDA – Get Free Report) last released its quarterly earnings results on Tuesday, November 10th. The company reported ($2.64) EPS for the quarter, missing the consensus estimate of $0.96 by ($3.60). The firm had revenue of $225.30 million for the quarter, compared to the consensus estimate of $214.18 million. Liquidia had a positive return on equity of 264.65% and a negative net margin of 15.15%. The firm’s revenue was up 314.9% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.04) EPS. On average, research analysts forecast that Liquidia will post 3.36 earnings per share for the current year.

Insider Activity at Liquidia

In other news, insider Sanjeev Khindri sold 1,101 shares of the stock in a transaction that occurred on Monday, October 12th. The shares were sold at an average price of $28.48, for a total value of $31,356.48. Following the completion of the transaction, the insider directly owned 64,846 shares in the company, valued at $1,846,814.08. This trade represents a 1.67% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Dana Boyle sold 1,581 shares of the company’s stock in a transaction that occurred on Monday, October 26th. The stock was sold at an average price of $43.19, for a total value of $68,283.39. Following the completion of the sale, the chief accounting officer owned 164,028 shares of the company’s stock, valued at $7,084,369.32. This trade represents a 0.95% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 358,232 shares of company stock worth $10,599,228 in the last three months. Insiders own 25.60% of the company’s stock.

Institutional Investors Weigh In On Liquidia

Several hedge funds and other institutional investors have recently bought and sold shares of LQDA. Pinnacle Wealth Planning Services Inc. lifted its holdings in Liquidia by 26.2% in the 3rd quarter. Pinnacle Wealth Planning Services Inc. now owns 1,557 shares of the company’s stock valued at $47,000 after acquiring an additional 323 shares during the last quarter. Sterling Capital Management LLC increased its holdings in shares of Liquidia by 839.1% in the third quarter. Sterling Capital Management LLC now owns 2,329 shares of the company’s stock valued at $70,000 after buying an additional 2,081 shares in the last quarter. Nisa Investment Advisors LLC increased its holdings in shares of Liquidia by 13.8% in the third quarter. Nisa Investment Advisors LLC now owns 2,634 shares of the company’s stock valued at $80,000 after buying an additional 320 shares in the last quarter. Globeflex Capital L P bought a new position in shares of Liquidia in the second quarter valued at $175,000. Finally, Nykredit A S acquired a new stake in shares of Liquidia during the 2nd quarter valued at $177,000. 64.54% of the stock is currently owned by institutional investors.

Liquidia Company Profile

(Get Free Report)

Liquidia Corporation is a biopharmaceutical company focused on developing and commercializing treatments for pulmonary hypertension and other serious diseases. Its work includes inhaled therapies designed to deliver medicines to the lungs. The company’s marketed product, Yutrepia (treprostinil) inhalation powder, is approved in the United States for adults with pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. Liquidia also has a pipeline of investigational therapies, including other formulations of treprostinil.

Further Reading

Analyst Recommendations for Liquidia (NASDAQ:LQDA)

Receive News & Ratings for Liquidia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia and related companies with MarketBeat.com's FREE daily email newsletter.